Post-approval studies (Phase 4)UnknownNCT01529255What this trial is testingEFFORT Extension StudyWho this might be right forHepatitis B, Chronic Nanfang Hospital, Southern Medical University 576
Post-approval studies (Phase 4)WithdrawnNCT00606099What this trial is testingEfficacy and Safety of Telbivudine in Patients With Chronic Hepatitis BWho this might be right forChronic Hepatitis B Novartis
Post-approval studies (Phase 4)Study completedNCT01088009What this trial is testingEfficacy Optimizing Research of Lamivudine TherapyWho this might be right forCompensated Chronic Hepatitis B Nanfang Hospital, Southern Medical University 366
Testing effectiveness (Phase 2)Study completedNCT00230503What this trial is testingDose-Ranging Study of Pradefovir in Patients With Compensated Hepatitis BWho this might be right forHepatitis B, Chronic Bausch Health Americas, Inc. 220
Large-scale testing (Phase 3)Ended earlyNCT02058108What this trial is testingStudy of Efficacy and Safety, Tolerability and Pharmacokinetics of Telbivudine in Children and Adolescents With Compensated Chronic Hepatitis B Virus InfectionWho this might be right forChronic Hepatitis B Novartis Pharmaceuticals 53
Post-approval studies (Phase 4)Study completedNCT00641082What this trial is testingRandomized Clinical Trial Comparing the Safety and Antiviral Activity of 48-week Clevudine and Adefovir Dipivoxil in HBeAg(-) Chronic Hepatitis B With Compensated Liver FunctionWho this might be right forHBeAg(-) Chronic Hepatitis B With Compensated Liver Function Bukwang Pharmaceutical 43
Post-approval studies (Phase 4)Study completedNCT00441974What this trial is testingAdefovir Dipivoxil For The Treatment Of Chinese Compensated Chronic Hepatitis B(CHB)PatientsWho this might be right forChronic Hepatitis B GlaxoSmithKline 1,470
Large-scale testing (Phase 3)Study completedNCT00316719What this trial is testingAdefovir Dipivoxil In Compensated Chronic Hepatitis B PatientsWho this might be right forChronic Hepatitis B GlaxoSmithKline 105
Testing effectiveness (Phase 2)Study completedNCT00804622What this trial is testingEffects of Telbivudine and Tenofovir Disproxil Fumarate on the Kinetics of Hepatitis B Virus DNA in Chronic Hepatitis B (CHB)Who this might be right forChronic Hepatitis B The University of Hong Kong 15
Post-approval studies (Phase 4)Study completedNCT00537537What this trial is testingTo Evaluate Antiviral Efficacy of Telbivudine in Hepatitis B Antigen Positive (HbeAg-positive) Compensated Chronic Hepatitis B (CHB)Who this might be right forHepatitis B, Chronic Novartis Pharmaceuticals 100
Post-approval studies (Phase 4)WithdrawnNCT00862706What this trial is testingEfficacy of Telbivudine in Blacks/African Americans and Hispanics/Latinos With Compensated Chronic Hepatitis B During 52 WeeksWho this might be right forCompensated Chronic Hepatitis B Novartis Pharmaceuticals
Post-approval studies (Phase 4)UnknownNCT04997564What this trial is testingThe Efficacy and Safety of 12-week SOF/VEL Regimen Combined With Prophylactic Use of TAF for Treatment-naïve Genotype 1-6 HCV/HBV Co-infection Adult Patients With or Without Compensated Cirrhosis in ChinaWho this might be right forChronic Hepatitis CChronic Hepatitis B Peking University First Hospital 120
Post-approval studies (Phase 4)Study completedNCT00467545What this trial is testingAn Extension to Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis BWho this might be right forChronic Hepatitis B Novartis Pharmaceuticals 44
Post-approval studies (Phase 4)Study completedNCT00877149What this trial is testingEfficacy of Telbivudine Treatment at Long Term on the Absence of Liver Inflammation in Patients With Compensated Chronic Hepatitis BWho this might be right forCompensated Chronic Hepatitis B Novartis Pharmaceuticals 80
Not applicableUnknownNCT04646928What this trial is testingStudy of Entecavir for Reducing the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B PatientsWho this might be right forChronic Hepatitis B CHA University 245
Large-scale testing (Phase 3)Study completedNCT01480284What this trial is testingPhase 3 Study of GSK548470 in Patients With Compensated Chronic Hepatitis B Untreated With Nucleic Acid AnalogueWho this might be right forHepatitis B, Chronic GlaxoSmithKline 166
Not applicableUnknownNCT04160897What this trial is testingRisk of Hepatocellular Carcinoma in Patients Treated With ETV vs TDF for Chronic Hepatitis B With Compensated CirrhosisWho this might be right forHepatitis B, ChronicHepatocellular CarcinomaCompensated Cirrhosis Qing XIe 4,000
Large-scale testing (Phase 3)Study completedNCT00057265What this trial is testingA Randomized, Double Blind Trial of LdT (Telbivudine) Versus Lamivudine in Adults With Compensated Chronic Hepatitis BWho this might be right forChronic Hepatitis B Novartis
Post-approval studies (Phase 4)Study completedNCT02224456What this trial is testingEfficacy and Safety Study of Tenofovir Disoproxil Fumarate (TDF) in Chinese Chronic Hepatitis B (CHB) Subjects With Advanced Fibrosis & Compensated CirrhosisWho this might be right forHepatitis B, Chronic GlaxoSmithKline 197
Large-scale testing (Phase 3)Study completedNCT00805675What this trial is testingEffects of Telbivudine and Tenofovir Disoproxil Fumarate Treatment on the Hepatitis B Virus DNA Kinetics in CHBWho this might be right forHepatitis B Virus Novartis Pharmaceuticals 83